India approves Biological E. COVID shot as a booster

FILE PHOTO: Coronavirus disease (COVID-19) vaccination drive for children aged 12 to 14 in Ahmedabad

(Reuters) - India has approved Hyderabad-based drugmaker Biological E's COVID-19 vaccine as the first mix-and-match booster dose in the country, the company said on Saturday.

The Drugs Controller General of India (DCGI) gave the nod for the Corbevax vaccine to be administerd as a booster shot to people age 18 years and over who have already received two doses of either AstraZeneca Plc's Covishield or Bharat Biotech's Covaxin.

(Reporting by Juby Babu in Bengaluru; Editing by Kirsten Donovan)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting